{"id":648,"date":"2012-06-21T10:05:08","date_gmt":"2012-06-21T10:05:08","guid":{"rendered":"https:\/\/blogs.bmj.com\/spcare\/?p=648"},"modified":"2012-06-21T10:05:08","modified_gmt":"2012-06-21T10:05:08","slug":"news-and-updates-from-www-palliativedrugs-com-23","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/spcare\/2012\/06\/21\/news-and-updates-from-www-palliativedrugs-com-23\/","title":{"rendered":"News and updates from www.palliativedrugs.com"},"content":{"rendered":"<p><strong><em>Selected items from the News and Latest Additions sections of <a href=\"http:\/\/www.palliativedrugs.com\/\">www.palliativedrugs.com<\/a>, the world\u2019s leading palliative care website.<\/em><\/strong><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Drug updates<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Study published on the impact of co-proxamol withdrawal<\/strong><\/p>\n<p>A time series study on the impact of co-proxamol withdrawal on prescribing and deaths in the UKhas been published. The study concludes that during the 6 years following the withdrawal of co-proxamol in the UK, there was a reduction in poisoning deaths involving this drug, without apparent significant increase in deaths involving other analgesics. For more information click <span style=\"text-decoration: underline\"><a href=\"http:\/\/www.plosmedicine.org\/article\/info:doi\/10.1371\/journal.pmed.1001213\">here<\/a><\/span>.<\/p>\n<p><strong><span style=\"text-decoration: underline\"><br \/>\n<\/span><\/strong><\/p>\n<p><strong>Cyclizine injection from Martindale recalled<\/strong><\/p>\n<p>Martindale Pharmaceuticals Ltd UKis recalling all remaining unexpired ampoules of cyclizine lactate injection 50mg\/mL, as a precautionary measure. The recall is due to a Good Manufacturing Practice (GMP) concern at a third-party supplier and their own site. It is likely that very little stock remains but the company wishes to minimize any potential patient risk.Recipients are requested to return any remaining stock to their normal supplier for credit. For more information click <span style=\"text-decoration: underline\"><a href=\"http:\/\/www.mhra.gov.uk\/Publications\/Safetywarnings\/DrugAlerts\/CON152853\">here<\/a><\/span>.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Biot\u00e8ne Oralbalance gel supply problem<\/strong><\/p>\n<p>There is aUKsupply problem with Biot\u00e8ne Oralbalance saliva replacement gel (GSK), this is due to a manufacturing problem at one of the companies owned by GSK. The product is out of stock and currently there is no information on when this is likely to be resolved. An alternative similar product is BioXtra salivia replacement gel (RIS Products). The Biot\u00e8ne Oralbalance mouth moisturizing liquid has previously been discontinued.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Latest additions<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Die zweite Ausgabe des APM Newsletter ist fertig.<\/strong><\/p>\n<p>The <span style=\"text-decoration: underline\"><a href=\"http:\/\/www.palliativedrugs.com\/download\/APM%20Newsletter22012fin2.pdf\">second issue of APM Newsletter<\/a><\/span><span>\u00a0<\/span>for German-speaking users of <a href=\"https:\/\/web.nhs.net\/owa\/redir.aspx?C=6906429716f74b139b4fdb976edfbf41&amp;URL=http%3a%2f%2fwww.palliativedrugs.com\" target=\"_blank\">www.palliativedrugs.com<\/a> is available.<\/p>\n<p style=\"text-align: right\">Die <span style=\"text-decoration: underline\"><a href=\"http:\/\/www.palliativedrugs.com\/download\/APM%20Newsletter22012fin2.pdf\">zweite Ausgabe<\/a><\/span>\u00a0des APM Newsletter ist fertig. \u00dcber die aktuelle Ausgaben des Newsletters wird Sie das Bulletin Board informieren.<\/p>\n<p><strong><em>\u00a0<\/em><\/strong><\/p>\n<p><strong>PCF monographs updated<\/strong><\/p>\n<p>The following Palliative Care Formulary (PCF) monographs have been updated and added to the formulary section of the <a href=\"http:\/\/www.palliativedrugs.com\/\">www.palliativedrugs.com<\/a> website. The following versions supersede the printed PCF4 book versions:<\/p>\n<p><span style=\"text-decoration: underline\"><a href=\"http:\/\/www.palliativedrugs.com\/formulary\/en\/propofol.html\">Propofol<\/a><\/span><span>\u00a0<\/span>(updated April 2012)<strong><em><\/em><\/strong><\/p>\n<p><a href=\"http:\/\/www.palliativedrugs.com\/formulary\/en\/danazol.html\"><span style=\"text-decoration: underline\">Danazol<\/span><em>\u00a0<\/em><\/a>(updated May 2012)<strong><\/strong><\/p>\n<p><a href=\"http:\/\/www.palliativedrugs.com\/formulary\/en\/bnf-5-1-11-13-10-1-2.html\"><span style=\"text-decoration: underline\">Metronidazole<\/span><span>\u00a0<\/span><\/a>(updated May 2012)<\/p>\n<p><span style=\"text-decoration: underline\"><a href=\"http:\/\/www.palliativedrugs.com\/formulary\/en\/progestogens.html\">Progestogens<\/a><\/span>\u00a0(updated May 2012)<\/p>\n<p><a href=\"http:\/\/www.palliativedrugs.com\/formulary\/en\/helicobacter-pylori-gastritis.html\">Helicobacter pylori gastritis<\/a> (updated May 2012).<\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>Prepared by Sarah Charlesworth and Andrew Wilcock<!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world\u2019s leading palliative care website. &nbsp; Drug updates &nbsp; Study published on the impact of co-proxamol withdrawal A time series study on the impact of co-proxamol withdrawal on prescribing and deaths in the UKhas been published. The study concludes that during the 6 [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/spcare\/2012\/06\/21\/news-and-updates-from-www-palliativedrugs-com-23\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":157,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2833],"tags":[],"class_list":["post-648","post","type-post","status-publish","format-standard","hentry","category-updates-from-www-palliativedrugs-com"],"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/posts\/648","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/users\/157"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/comments?post=648"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/posts\/648\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/media?parent=648"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/categories?post=648"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/tags?post=648"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}